Additionally, another study demonstrated that liraglutide not only significantly reduces postprandial glucagon excursions in a dose-dependent manner but also suppresses fasting plasma FFAs concentrations, thereby attenuating ketogenesis in patients with T1DM [57]. This evidence concerns the gene GCG and type 1 diabetes mellitus.